Introduction
Improving the binding affinity of al igand binding to at arget protein is am ain optimization parameter in drug design. In contrastt oe xperiments,c omputational approaches have the advantage of not being dependento nt he actual physical existence of ac ertain ligand. Hence, these approaches can be used to estimate the bindinga ffinity and prioritize compounds prior to synthesis. Significant progress in calculating binding affinities hasbeen made in recent years.
[1] Thanks to substantially increased computational performance of modern graphic cards, these simulation-based techniques are now also fast enough to match drug design projectt imelines.
It has been shown that ligands with macrocyclic structure can provides everala dvantages such as diversef unctionality, high binding affinity and selectivity.
[2] Especially for challenging targets,m acrocyclesc an lead to well-suited drug candidates. [3] Nevertheless, broad interest in syntheticm acrocyclesi sarelatively youngp henomenon. [4] To the best of our knowledge, this is the first study to investigate whether or not accurate and reliable computational estimates of binding affinities of macrocyclic ligandsc an be obtained and whether these estimates are robustw ith respectt o changes of protein or ligand conformations. This study uses a version of the Schrçdinger Suite [5] which contains an improved version of FEP + which allows for ring openinga nd closing. [5e, 6] Furthermore, we figure and point out chances and challenges of designingm acrocycles based on non-macrocyclic ligands using "LigMac" (see Supporting Information), an ovel tool in this area of research.
We examine five diverse pharmaceutical targets:t he receptor tyrosine kinase anaplastic lymphoma kinase (ALK), [7] the serine protease factor 7( FVII), [8] farnesyltransferase (FTase), [9] the phosphohydrolase MTH1, [10] and the bromodomain-containingp rotein 4( BRD4). [11] 
Results
The comparison of experimental and calculated binding affinity for all targets is shown in Figure 1 . Nearly all simulated values agree with experiment within 1kcal mol
À1
.F urthermore, the estimates of equivalent simulations are in general very similar. Simulations a) and b) are run to study the robustness of the simulation protocol with respect to small changes in the initial protein structure. Simulation c) mimics the design situation where the ligand's conformation inside the protein binding pocket is not known apriori. An overview of the different simulationsi sg iven in Table 1 . Detailed information about the calculated binding affinitiescan be found in Tables 2-6. An ecessary,y et not sufficient condition for convergence is cycle closure hysteresis. In this study we observedh ystereses ranging from 0.1 to 1.7 kcal mol À1 (see Table S1 ). Theb est converged results were obtained for the smallest protein in the set BRD4 (cycle closure hysteresis smaller than 0.5 kcal mol À1 for all simulations), whereas the largest protein, FTase, showed the slowest convergence( hysteresis up to 1.7 kcal mol À1 )s uggesting that more precise results could be obtained for this target by prolonging the simulationt ime.
Macrocycles play an increasing role in drug discovery,b ut their synthesis is often demanding. Computational tools that suggest macrocyclization based on ak nown bindingm ode and that estimate the binding affinity of these macrocycles could have as ubstantial impact on the medicinal chemistry design process. For both tasks, we established aw orkflow with high practical value. For five diversep harmaceutical targets we show that the effect of macrocyclization on binding can be calculated robustly anda ccurately.A pplying this method to macrocycles designed by LigMac, as earch tool for de novo macrocyclization,o ur results suggest that we have ar obust protocol in hand to design macrocyclesa nd prioritize them prior to synthesis.
Besides computationally demanding methods like FEP + , [1c] there are alternative approaches to calculate binding affinities such as MM-GBSA. [12] Because it makes more approximations, it is faster than FEP + .T he results obtained by MM-GBSA are displayed in SupportingI nformation Figure S1 . Comparing with the FEP + results (Figure 1 ) it can be seen that the higher computational investment does lead to substantially improved estimates.
The following resultsa re obtained using LigMac,atool to find possible macrocyclesf or ag iven, non-macrocyclic ligand in the context of the binding site. Ad escription of LigMac can be found in the Supporting Information. In this study,w eu sed carbon-only linkers. We applied LigMac to one structure per target. The structures used were 4CNH [7] (ALK), 4ZXX [8] (FVII), 1S63
[9b] (FTase),5 ANT [10] (MTH1) and5 UEY [11] (BRD4). LigMac returns different numberso fp ossible macrocycles in different conformations. Figure 2d isplays an example macrocycle designed with LigMac and the originall igand 27 (5ANT,T able 3).
Due to the computational complexity of FEP + ,i tw as not possible to run it for all LigMac suggestions. To rank all resulting ligands, we considered different metrics. One strategy was to investigate whetherL igMac generates macrocycles that are close to the known literaturem acrocycle. To this end we compared all LigMac macrocyclest ot he known macrocycle crystal structure by the RMSD of the coordinates of the linker atoms (metric 1, see experimental section for details). This strategy is, however,o nly possible if one has such am acrocycle crystal Table 1 ) are shown. ALK is plotted in red, FVII is blue, FTase is green, MTH1i sg rey,a nd BRD4 is orange. The black line represents the ideal estimate, andthe grey linese nclose the area of an errors maller than 1kcal mol
.Please note that calculated DDG valuesweretransformed into DG values by takingt he mean of all experimental data points per target as reference.T his impliest hat only the correlation within one target (one color)i s meaningfulbut not the overallc orrelation (all colors). Error bars on experimentaldata are used for ALK to indicate the experimental data points labeled with " < ". Table 1 . Setup for simulations a), b), and c).
[a]
Simulation
Protein structure Ligand 123
[a] NL:n on-macrocyclic ligand,P NL:a ssociated protein crystal structure. ML is am acrocyclic ligand similar to NL and PML its native protein crystal structure. DL is obtainedb yd ocking ML into PNL,a nd 3L is at hird ligand needed to calculate the cycle-closureh ysteresis. For ALK and BRD4,a ll structures are taken from PDB files.F or all other targets,3 Lw as modelled because there was no similar ligand available in the PDB. Mored etails on starting coordinates and protein structuresa re listed in Supporting Information Ta ble S1. Table 2 . Calculated binding affinities for ALK.
6b (4CNH) 6i (4CMT) 8a (4CMU) Compd in Lit. [7] Exp. IC 50 [nm]Exp. RT ln IC 50 Calc. RT ln IC 50 a) b) c)
[a] RelatedP DB codesa re given in parentheses. The starting coordinates in a)a nd c) of compound 8a havea nR MSD of 0.72 .A ll RT ln IC 50 values are given in kcal mol
À1
. ChemMedChem 2017 ChemMedChem , 12,1866 ChemMedChem -1872 www.chemmedchem.org 2017 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim structurea vailable. Our aim, however,i st oa pply LigMac especially to examples, where there is no known macrocycle. We therefore tried MM-GBSA for all LigMac results. Af avorable MM-GBSA score, however,o ften seemed to be coupled with large, hydrophobic carbon loops that probably do not come with the advantages mentioned in the introduction.
[2] Away to improvet his was to calculate the energetic efficiency of the added structure by dividing the MM-GBSA score by the length of the linker (metric 2).
For each target we performed one FEP + simulation including the non-macrocyclic ligand using its crystal structure starting coordinates and the best resultsf rom LigMac in metrics 1 and 2, respectively.T he protein structure is taken from the non-macrocyclic ligand. Our results are illustrated in Figure 3 .
Discussion
One key insight of our work is that differences in experimental binding affinitiesc an be reproduced very well for macrocyclic and non-macrocyclic ligands. Comparing Figure 1a nd Figure S1 it is also clear,t hat the higher computational demand of FEP + leads to more accurate results than the rather simple and fast version of MM-GBSA used in this study.A dditionally, FEP + results are very robust regarding changes in the initial protein structure unlike MM-GBSA where the values of simulation a) and b) differ significantly.W ew ill therefore focus on data obtained by FEP + in the following discussion.
We discuss all examples individually starting with ALK. For this target, all computed binding affinitiesm atch the experi- Table 3 . Calculated binding affinities for MTH1. [a] Compd in Lit. [10] RR . Figure 3 . Change in binding affinity going from the five non-macrocyclic ligandsw eu sed for LigMac to different macrocycles.Blue indicates experimentally observed binding affinity changes when going from an open-chain molecule to published macrocycles 8a (4CMU, [7] ALK), 4 (4ZXY, [8] FVII), 66 (1LD7, [9a] FTase), 15 (5ANU, [10] MTH1), and 61 a (5UEX, [11] BRD4). For each target the open-chain reference molecules are 6b (ALK), 1 (FVII), 2 (FTase), 27 (MTH1), and 25 e (BRD4). Red and green indicate calculated (FEP +)b inding affinity changesf or the best ligands according to metrics 1a nd 2, respectively.All simulated LigMac macrocycles can be found in Supporting InformationT able S2. An egativechangei ndicates stronger binding. For ALK, there is one ligand scoring highest in bothmetrics. Its calculated binding affinity is identical to the bindinga ffinity of the non-macrocyclic ligand 6b (4CNH,T able 2), and therefore the changei s0 .P lease note that the indicated experimentalb indinga ffinity difference for ALK is an upperb ound. )i ndicating that the simulations are very robust with respect to slightly different ligand starting conformations.R esults from simulationb )a re also similart oe xperimental resultsm eaningt here is no strong dependence of the initial protein structure used on the calculated affinities. The mean unsignede rror (MUE) and R 2 could not be calculated for ALK as precise experimental binding affinity measurements were only available for compound 6b.
For MTH1,a ll simulations return data very close to experimental results (R 2 ! 0.98). Interestingly,t he mean unsigned error in simulation c) is higher than in a) althoughl igand starting coordinates differed only by 0.13 .T herefore, the difference in MUE is likely not due to the difference in ligand starting conformation but an indication of the intrinsic variation (precision) of these calculations.
FVII resultss how as imilarb ehavior:W hile R 2 is very close to 1f or all simulations, the mean unsigned error in c) is relatively high (MUE = 1.5 kcal mol À1 )c omparedt oa )a nd b) (MUE = 0.7 and 0.9 kcal mol À1 ,r espectively). Very robust (i.e.,i ndependento ft he initial protein and/or ligand starting coordinates) and accurate (i.e.,i na greement with experiment)r esults could also be obtained for FTasea nd BRD4. All calculated binding affinitiesm atched the experimental values with MUEs of 0.4 and 1.2 kcal mol À1 and R 2 of ! 0.84 and ! 0.88, respectively.
Our results are very encouraging, but we would like to point out that FEP + was not applicable to all targets we planned to include in this study.T here were four further data sets of interest. b-Secretase 1 [13] and Heat shock protein 90 [14] could not be included due to atom mappingp roblemso fF EP + .T he problems have been reported to the developers and will be fixed in forthcomingv ersions.T wo furthers ystems had to be excluded because the experimental data was not suited upon closer inspection:F or casein kinase 2, [15] the protein constructs forc rystallization and biochemical assay came from different species and for cyclin-dependentk inase 2 [16] the crystal structure was lacking the cyclin whereas the assay was run with cyclin E.
The aim of LigMac is to find strongly binding macrocycles on the basis of ag iven, non-macrocyclic ligand. All LigMac compounds (including the original non-macrocyclic basis) for which we performed FEP + calculations are shown in Supporting Information Table S2 .
For ALK, there is aw ell bindingm acrocycle 8a (4CMU, exp. IC 50 < 0.2 nm,s ee Ta ble 2) andaless strongly binding non-macrocyclic ligand 6b (4CNH, exp. IC 50 4nm,T able 2) that, besides the actual cycle, only differs in one five membered ring being ap yrazole in compound 8a and at riazole in compound 6b.A furthercomputationalFEP + study (see Supporting Information Ta ble S3)s uggests that macrocyclization alone does not lead to ap otencyi mprovement but is only advantageous in combination with this pyrazole. Due to the fact that LigMac builds all macrocycles on the basis of 6b having triazole, finding am acrocycle that was estimated to be as potent as 8a was rather unlikely.H owever,t he LigMac ligand scoring highest in both metrics (i.e. closest to literature macrocycle 8a in terms of linker RMSD and top ranked by MM-GBSA) performs as well as the non-macrocyclic ligand 6b andi si denticalt o8a with respect to linker length and distribution of sp 2 and sp 3 centers. In the FVII data set, macrocycle 4 (4ZXY,T able 4) has av ery weak bindinga ffinity (IC 50 = 920 nm)r elative to the non-macrocyclic ligand 1 (4ZXX,T able 4), whose IC 50 is 8nm. [8] Additional FEP + calculations (see Table S4 ) suggest that this loss of affinity is due to the lack of as ulfone group in the macrocycle and Table 4 . Calculated binding affinities for FVII. [a] Compd in Lit. [8] RR that macrocyclizationw ith al inker as in 4 does not have an influence on potency.F or the LigMac generated macrocyclesw e observe mixed results: The best ligand in metric 1i ssuggested to be better binding than ligand 1 and the bestl igand from metric 2isc alculated to be worse binding than 1.
All three chosen FTase literature ligandsa re in the same range of binding affinity (IC 50 from 1.1 to 4.9 nm), [9a] even thought he structure of macrocycle 66 (1LD7, Ta ble5)d iffers from the open-chain ligand 2 (1S63, Table 5 ) more than in other data sets. This scaffold difference is the reasonw hy LigMac macrocycles are not easily comparable with the literature macrocycle. Nevertheless the macrocycle suggested by metric 2i st he best ligand we simulated for this target,s oo ur calculations suggest that is possible to improve binding to FTase by macrocyclization.
Following Kettle et al., [10] the literature macrocycle for MTH1 15 (5ANU, Ta ble 3) combines two advantages:I th as av ery polar linker and locks the polar centers in af avorable position. Because we use LigMac with generic carbon linkerso nly,n one of LigMac's resultsi sa ble to close the macrocycle with ah ydrophilic linker.I ti st herefore not surprising that the estimated binding affinities of the LigMac designed macrocycles are much weakert han that of macrocycles 15.
Concerning the BRD4 dataset,t he two ligands proposed by metric1and 2( see Supporting Information Ta ble S2) are very similart ot he literature macrocycle 61 a (5UEX, Ta ble 6). Similar to the results obtainedf or FTase, the BRD4 resultss uggest that potent macrocycles can be identified by our procedure. The LigMac designed macrocycle resulting from metric 2i sc alculated to be as trongerb inder than the literature macrocycle . Table 6 . Calculated binding affinities for BRD4.
11 (5UEZ) 25 e (5UEY) 61 a (5UEX) Compd in Lit. [11] Exp. IC 50 61 a (see Figure 3 , green bar). On the other hand, macrocyclic structures are not necessarily better,w hich can be seen looking at the LigMac suggestionc losest to the literature macrocycle 61 a (in terms of linker atoms RMSD, that is, metric 1) suggested to be worse (see Figure 3 , red bar)t han the non-macrocyclic ligand 25 e (5UEY,T able 6).
In future work we plant oe xtendt he genericl inker library by non-generic, hydrophilic linkers. The evaluation of further metrics, such as for example, estimated ligand-lipophilicity efficiency, [17] will help to decrease the number of proposed macrocycles to an umber manageable for FEP + .
Conclusions
We show that the effect of macrocyclization on bindinga ffinity can be reproduced by calculations with good accuracy.M oreover,t he results obtaineda re robust with respect to changes of the initial protein structure on the one hand and changes in the ligands' startingc onformations on the otherh and. We also observe good agreement of calculated and experimental affinities when using dockedm acrocycles as input conformations. Hence we conclude that we have arobustprotocol to evaluate the binding affinity of self-designed macrocycles in ap rospective setting.
Our results in macrocycle design using LigMac suggest that LigMac in combination with binding affinity calculations allows designing highly potent macrocycles. Future work will extend the linker library which is an important step towardo pening the way to al arger chemical space.
Experimental Section
The platform for our work was Schrçdinger's Maestro (version 2017-1) . [5a] All crystal structures were taken from the PDB [18] and were preprocessed using the Protein Preparation Wizard
[5b] as follows. No waters were deleted. In case of missing loops or side chains, the missing parts were filled in using Prime.
[5c] For structures containing several chains, we chose chain Aa nd deleted all other chains and associated ligands. Furthermore, non-water solvent molecules stemming from the crystallization buffer were deleted. Protonation states were assigned corresponding to pH 7. The hydrogen bonding network was optimized, followed by restrained minimization using the OPLS3 force field. [19] For docking jobs with Glide,
[5f] grids were prepared using default settings. Docking was done in standard precision with flexible ligand sampling. Nitrogen inversions and ring conformations were sampled. Ligand input conformations were canonicalized. Ac ore constraint was applied using the largest common substructure shared by all three ligands and the non-macrocyclic ligand (Ligand 1, see Ta bles 1a nd S1) as reference. By default, the tolerance of this core constraint was 0.1 .I ft his setting did not lead to any docked result, the procedure was retried with 1 tolerance. Only the binding pose with the best docking score was used during the following calculations.
Prime MM-GBSA [5c] was used in combination with the OPLS3 [19] force field. The protein was allowed to relax within 5 of the ligand. To make MM-GBSA values comparable with FEP + results, we added an offset to the calculated affinities (DG values) such that the mean of all calculated values for each simulation and target matched the experimental values.
To prepare the ligands for FEP + , [5e, 6] missing torsional parameters were calculated using the Force Field Builder. [19] The FEP Mapper was then used to set up the simulation. An improved version of FEP + was used that allows ring opening and closing. [6] For all data sets, all possible perturbations were calculated. The simulation time was set to 20 ns. For simulations of the protein-ligand complexes, the buffer width was set to 10 .F or ligand-in-solvent simulations, the buffer was increased to 15 .T he non-bonded interaction cutoff radius was increased to 13 only in solvent. This larger cutoff was necessary in version 2017-1 to ensure that if nonmacrocyclic ligands adopted an extended conformation in solvent, no (dummy) bond exceeded the cutoffr adius. Default parameters were used for all other FEP + simulation parameters.
[1c] The optimal estimatesofthe relative free energies were obtained from thecalculatedfree energy differencesasdetailedinAppendixAof thereport by Wang et al. [20] Ther elativef ree energies (DDG values)w eret hen transformed into absolute free energies (DG values) by taking the mean of all experimental data points per target as reference.
The program LigMac was used to generate macrocycles based on one non-macrocyclic ligand for each of the five targets. LigMac first generates ac onformer ensemble of linker fragments. These linkers are then used to connect two distant atoms within the ligand to form am acrocycle. In al ast step macrocycles that clash with the protein or do not fulfill certain geometrical parameters are discarded. LigMac was applied to the PDB file of the non-macrocyclic ligand crystal structure with two different linker libraries. RMSD calculations for the docked macrocycle in simulation c) were performed by superposition of all atoms. Finding the generated macrocycle closest to the literature one was done in several steps. First, the linker in the literature macrocycle was identified. Then, all heavy non-carbon atoms were changed to carbon, keeping the original hybridization. The RMSD was then calculated without further superposition taking into account only the atoms of the generated dummy linker.
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